Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jovanovic

Showing results (151-160 of 157) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 157 results.
The New England Journal of Medicine|December 22, 1988
Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conceptionJ L Mills, J L Simpson, S G Driscoll, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 29, 2014
Twenty nevi on the arms: a simple rule to identify patients younger than 50 years of age at higher risk for melanomaGiuseppe Argenziano, Jason Giacomel, Iris Zalaudek, et al.
Diabetes Care|May 1, 1992
Early sonographic evaluation for fetal growth delay and congenital malformations in pregnancies complicated by insulin-requiring diabetes. National Institute of Child Health and Human Development Diabetes in Early Pregnancy StudyZ A Brown, J L Mills, B E Metzger, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2004
The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial resultsD M Reboussin, D C Goff, E W Lipkin, et al.
Acta Dermato-Venereologica|March 28, 2009
Lack of association between neuropeptide S receptor 1 gene (NPSR1) and eczema in five European populationsElisabeth Ekelund, Maria Bradley, Stephan Weidinger, et al.
Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
Pageof 16

Showing results (151-160 of 157) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 157 results.
The New England Journal of Medicine|December 22, 1988
Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conceptionJ L Mills, J L Simpson, S G Driscoll, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 29, 2014
Twenty nevi on the arms: a simple rule to identify patients younger than 50 years of age at higher risk for melanomaGiuseppe Argenziano, Jason Giacomel, Iris Zalaudek, et al.
Diabetes Care|May 1, 1992
Early sonographic evaluation for fetal growth delay and congenital malformations in pregnancies complicated by insulin-requiring diabetes. National Institute of Child Health and Human Development Diabetes in Early Pregnancy StudyZ A Brown, J L Mills, B E Metzger, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 24, 2004
The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial resultsD M Reboussin, D C Goff, E W Lipkin, et al.
Acta Dermato-Venereologica|March 28, 2009
Lack of association between neuropeptide S receptor 1 gene (NPSR1) and eczema in five European populationsElisabeth Ekelund, Maria Bradley, Stephan Weidinger, et al.
Oncogene|June 9, 2016
A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancerL A Selth, R Das, S L Townley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2015
EVERSUN: a phase 2 trial of alternating sunitinib and everolimus as first-line therapy for advanced renal cell carcinomaI D Davis, A Long, S Yip, et al.
Pageof 16